Deutsche Bank Starts Clover Health (CLOV) at Buy
Tweet
Share
E-mail
Get Alerts CLOV Hot Sheet
Price: $4.34 --0%
Rating Summary:
3 Buy, 4 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 13 | New: 29
Rating Summary:
3 Buy, 4 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 13 | New: 29
Join SI Premium – FREE
Deutsche Bank analyst George Hill initiates coverage on Clover Health (NASDAQ: CLOV) with a Buy rating and a price target of $6.00.
For an analyst ratings summary and ratings history on Clover Health click here. For more ratings news on Clover Health click here.
Shares of Clover Health closed at $4.34 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oppenheimer Starts Aehr Test Systems (AEHR) at Outperform, 'AI Burn-In Inflection Underappreciated'
- American Eagle Outfitters (AEO) PT Lowered to $27 at UBS, Buy Rating Maintained
- MolDX proposes Medicare coverage for genome-wide hematologic testing
Create E-mail Alert Related Categories
New CoverageRelated Entities
Deutsche Bank, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
